Literature DB >> 7605114

Inhibition of herpes simplex virus type 1, respiratory syncytial virus and echovirus type 11 by peroxidase-generated hypothiocyanite.

H Mikola1, M Waris, J Tenovuo.   

Abstract

The human mouth is an important route of viral transmission and evidence exists that human saliva can neutralize some viruses, e.g. herpes simplex type 1 (HSV-1) and human immunodeficiency virus (HIV) in vitro. However, little is known of the actual antiviral agents in saliva. We have analyzed how hypothiocyanite (HOSCN/-OSCN) ions, present in human saliva and generated by salivary peroxidase systems, affect the viability of three different types of viruses; HSV-1 (capable of inducing oral lesions), respiratory syncytial virus (RSV, respiratory infections), and echovirus 11 (EV 11, enteric diseases). Viral suspensions were pretreated (30 min) with HOSCN/-OSCN concentrations up to 180 microM both at pH 6.0 and 7.1 and inoculated into human gingival fibroblasts. The cultures were incubated at 37 degrees C for 18-48 h, fixed and the infected cells were counted after immunoperoxidase staining. HSV-1 was most sensitive to HOSCN/-OSCN with an IC50 of 8.5 microM at pH 6.0 and an IC50 of 20 microM at pH 7.1, respectively. RSV was inhibited by HOSCN/-OSCN only at pH 6.0 with an IC50 of 8.0 microM. EV 11 was also resistant at neutral pH, but sensitive at pH 6.0 with an IC50 of 68 microM. In contrast to HSV-1 and RSV, the inhibition of EV 11 was not dependent on the concentration of HOSCN/-OSCN. The inhibition was in all cases stronger at pH 6.0 than at neutral pH. Our results suggest that hypothiocyanite, a normal component of human whole saliva, in physiological concentrations effectively inhibits HSV-1 and RSV at acidic pH, whereas EV 11 is more resistant in vitro.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7605114     DOI: 10.1016/0166-3542(94)00073-h

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  20 in total

Review 1.  Topical antimicrobials for burn infections - an update.

Authors:  Mert Sevgi; Ani Toklu; Daniela Vecchio; Michael R Hamblin
Journal:  Recent Pat Antiinfect Drug Discov       Date:  2013-12

Review 2.  Antimicrobial actions of dual oxidases and lactoperoxidase.

Authors:  Demba Sarr; Eszter Tóth; Aaron Gingerich; Balázs Rada
Journal:  J Microbiol       Date:  2018-06-01       Impact factor: 3.422

Review 3.  Biochemical mechanisms and therapeutic potential of pseudohalide thiocyanate in human health.

Authors:  Joshua D Chandler; Brian J Day
Journal:  Free Radic Res       Date:  2015-01-28

4.  The thiocyanate analog selenocyanate is a more potent antimicrobial pro-drug that also is selectively detoxified by the host.

Authors:  Brian J Day; Preston E Bratcher; Joshua D Chandler; Matthew B Kilgore; Elysia Min; John J LiPuma; Robert J Hondal; David P Nichols
Journal:  Free Radic Biol Med       Date:  2019-11-15       Impact factor: 7.376

5.  IFNβ/TNFα synergism induces a non-canonical STAT2/IRF9-dependent pathway triggering a novel DUOX2 NADPH oxidase-mediated airway antiviral response.

Authors:  Karin Fink; Lydie Martin; Esperance Mukawera; Stéfany Chartier; Xavier De Deken; Emmanuelle Brochiero; Françoise Miot; Nathalie Grandvaux
Journal:  Cell Res       Date:  2013-04-02       Impact factor: 25.617

Review 6.  Lactoperoxidase: structural insights into the function,ligand binding and inhibition.

Authors:  Sujata Sharma; Amit Kumar Singh; Sanket Kaushik; Mau Sinha; Rashmi Prabha Singh; Pradeep Sharma; Harshverdhan Sirohi; Punit Kaur; Tej P Singh
Journal:  Int J Biochem Mol Biol       Date:  2013-09-13

7.  Nebulized thiocyanate improves lung infection outcomes in mice.

Authors:  J D Chandler; E Min; J Huang; D P Nichols; B J Day
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

8.  Molecular heterogeneity and alternative splicing of human lactoperoxidase.

Authors:  Miryam A Fragoso; Aliza Torbati; Nevis Fregien; Gregory E Conner
Journal:  Arch Biochem Biophys       Date:  2008-11-24       Impact factor: 4.013

9.  Thiocyanate: a potentially useful therapeutic agent with host defense and antioxidant properties.

Authors:  Joshua D Chandler; Brian J Day
Journal:  Biochem Pharmacol       Date:  2012-08-08       Impact factor: 5.858

10.  Effect of lactoperoxidase on the antimicrobial effectiveness of the thiocyanate hydrogen peroxide combination in a quantitative suspension test.

Authors:  A Welk; Ch Meller; R Schubert; Ch Schwahn; A Kramer; H Below
Journal:  BMC Microbiol       Date:  2009-07-09       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.